This PhD scholarship at the University of Newcastle offers an exciting opportunity for candidates with experience in targeting therapy in cancer to contribute to the development of novel approaches for the treatment of thyroid cancer. The successful applicant will work under the supervision of NHMRC fellow and Laureate Professor Roger Smith, in affiliation with the Hunter Medical Research Institute, a leading center for medical research in Australia.

The project focuses on innovative cancer therapeutics, specifically targeting thyroid cancer, and aims to translate laboratory findings into clinical applications. Candidates will be involved in cutting-edge research, collaborating with experts in oncology and medical science, and will have access to state-of-the-art facilities and resources provided by the Hunter Medical Research Institute.

The scholarship provides a generous living allowance of $38,938 per annum (2026 rate), indexed annually, and covers tuition fees for 3.5 years. Additionally, successful candidates may receive up to $1,500 as a relocation allowance. The award is contingent upon the full establishment of grant funding.

Eligibility is restricted to domestic students who meet the minimum PhD admission criteria at the University of Newcastle. Applicants should demonstrate prior experience in cancer therapy targeting and must submit a comprehensive application package, including academic transcripts, CV, a statement of research interests, and a proposal that aligns with the research project.

Applications must be submitted via email to [email protected] by 5pm on 11 January 2026. For further details and to review the scholarship information, candidates are encouraged to visit the official university scholarship page. This is a unique opportunity to advance your research career in medical science and contribute to impactful cancer research.